Contemporary diagnosis and epidemiological trends of mucormycosis: a call for action and caution.
作者信息
Rudramurthy Shivaprakash M, Muthu Valliappan, Agarwal Ritesh
机构信息
Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India.
Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India.
出版信息
Lancet Reg Health Eur. 2024 Aug 21;45:101039. doi: 10.1016/j.lanepe.2024.101039. eCollection 2024 Oct.
Abstract
摘要
相似文献
1
Contemporary diagnosis and epidemiological trends of mucormycosis: a call for action and caution.毛霉菌病的当代诊断与流行病学趋势：呼吁行动与谨慎
Lancet Reg Health Eur. 2024 Aug 21;45:101039. doi: 10.1016/j.lanepe.2024.101039. eCollection 2024 Oct.
2
Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases.儿童患者中的毛霉菌病：12 例当代病例的人口统计学、危险因素和转归。
Mycoses. 2011 Nov;54(6):e785-8. doi: 10.1111/j.1439-0507.2011.02025.x. Epub 2011 May 30.
3
Epidemiology of Mucormycosis Cases During the Second Wave of COVID-19 in a Tertiary Care Institute in Western Rajasthan, India.印度拉贾斯坦邦西部一家三级医疗机构中第二波新冠疫情期间毛霉菌病病例的流行病学情况
Cureus. 2022 Mar 8;14(3):e22973. doi: 10.7759/cureus.22973. eCollection 2022 Mar.
4
Epidemiology and prognostic factors of mucormycosis in France (2012-2022): a cross-sectional study nested in a prospective surveillance programme.法国毛霉病的流行病学及预后因素（2012 - 2022年）：一项纳入前瞻性监测项目的横断面研究
Lancet Reg Health Eur. 2024 Aug 7;45:101010. doi: 10.1016/j.lanepe.2024.101010. eCollection 2024 Oct.
5
Fatal disseminated mucormycosis associated with COVID-19.与新型冠状病毒肺炎相关的致死性播散性毛霉病
Respirol Case Rep. 2022 Feb 13;10(3):e0912. doi: 10.1002/rcr2.912. eCollection 2022 Mar.
6
Mucormycosis: its contemporary face and management strategies.毛霉病：其当代特征与治疗策略。
Lancet Infect Dis. 2011 Apr;11(4):301-11. doi: 10.1016/S1473-3099(10)70316-9.
7
[Research progress of mucormycosis in burns].[烧伤毛霉病的研究进展]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Dec 20;39(12):1195-1200. doi: 10.3760/cma.j.cn501225-20231101-00165.
8
Performance of Mucorales spp. qPCR in bronchoalveolar lavage fluid for the diagnosis of pulmonary mucormycosis.毛霉目 qPCR 在支气管肺泡灌洗液中对肺毛霉病诊断的性能。
Med Mycol. 2024 Jan 27;62(2). doi: 10.1093/mmy/myae006.
9
Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases.提高肺毛霉菌病诊断水平：来自 114 例当代全国性研究的线索。
Chest. 2023 Nov;164(5):1097-1107. doi: 10.1016/j.chest.2023.06.039. Epub 2023 Jul 5.
10
Epidemiology of mucormycosis in Europe.欧洲毛霉病的流行病学。
Clin Microbiol Infect. 2014 Jun;20 Suppl 6:67-73. doi: 10.1111/1469-0691.12563. Epub 2014 Mar 6.
引用本文的文献
1
2
Real-World Effectiveness and Safety of Isavuconazole Versus Amphotericin B for Patients with Invasive Mucormycosis.艾沙康唑与两性霉素B治疗侵袭性毛霉病患者的真实世界有效性和安全性
Microorganisms. 2025 Jan 1;13(1):55. doi: 10.3390/microorganisms13010055.
本文引用的文献
1
Epidemiology and prognostic factors of mucormycosis in France (2012-2022): a cross-sectional study nested in a prospective surveillance programme.法国毛霉病的流行病学及预后因素（2012 - 2022年）：一项纳入前瞻性监测项目的横断面研究
Lancet Reg Health Eur. 2024 Aug 7;45:101010. doi: 10.1016/j.lanepe.2024.101010. eCollection 2024 Oct.
2
A novel indirect ELISA for serodiagnosis of mucormycosis using antigens from Rhizopus arrhizus.一种新型的间接 ELISA 用于罗萨隐球菌抗原检测毛霉病的血清学诊断。
Mycoses. 2024 May;67(5):e13730. doi: 10.1111/myc.13730.
3
Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.多国多中心 COVID-19 相关毛霉菌病爆发的病例对照研究，印度。
Emerg Infect Dis. 2023 Jan;29(1):8-19. doi: 10.3201/eid2901.220926.
4
The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.欧洲实验室真菌学现状及抗真菌治疗可及性：欧洲医学真菌学联合会调查
Lancet Microbe. 2023 Jan;4(1):e47-e56. doi: 10.1016/S2666-5247(22)00261-0. Epub 2022 Dec 1.
5
Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial.血清接合菌聚合酶链反应（PCR）在毛霉病诊断中的评估：MODIMUCOR 前瞻性试验。
Clin Infect Dis. 2022 Sep 14;75(5):777-785. doi: 10.1093/cid/ciab1066.
6
A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.一项关于印度毛霉菌病的流行病学、危险因素、治疗和结局的多中心观察性研究。
Clin Microbiol Infect. 2020 Jul;26(7):944.e9-944.e15. doi: 10.1016/j.cmi.2019.11.021. Epub 2019 Dec 4.
7
The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials.基于 PCR 的艰难梭菌感染诊断的风险：临床试验的惨痛教训。
Anaerobe. 2019 Dec;60:102048. doi: 10.1016/j.anaerobe.2019.06.001. Epub 2019 Jun 12.
8
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.欧洲接合菌病：欧洲医学真菌学会（ECMM）接合菌病工作组 2005 年至 2007 年登记的 230 例病例分析。
Clin Microbiol Infect. 2011 Dec;17(12):1859-67. doi: 10.1111/j.1469-0691.2010.03456.x. Epub 2011 Jul 1.
9
PCR-based diagnosis of human fungal infections.基于聚合酶链反应的人类真菌感染诊断。
Expert Rev Anti Infect Ther. 2009 Dec;7(10):1201-21. doi: 10.1586/eri.09.104.
10
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组（EORTC/MSG）共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.
Zotero 插件